577778-86-0 Usage
Uses
Used in Organic Synthesis:
2-[(1,1-diMethylethoxy)carbonyl]hydrazide, 1-oxide is used as a reagent in organic synthesis for its ability to participate in various chemical reactions, facilitating the formation of complex organic compounds.
Used in Pharmaceutical Production:
As a building block, 2-[(1,1-diMethylethoxy)carbonyl]hydrazide, 1-oxide is utilized in the production of pharmaceuticals, contributing to the development of new drugs and improving existing ones through its unique structural properties.
Used in Medicinal Chemistry:
2-[(1,1-diMethylethoxy)carbonyl]hydrazide, 1-oxide is employed in medicinal chemistry for its potential biological activity, which can be harnessed to create new therapeutic agents or enhance the efficacy of existing treatments.
Used in Drug Development:
In the field of drug development, 2-[(1,1-diMethylethoxy)carbonyl]hydrazide, 1-oxide serves as a promising candidate for the discovery of novel pharmaceuticals, given its unique chemical structure and potential to interact with biological targets.
Check Digit Verification of cas no
The CAS Registry Mumber 577778-86-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 5,7,7,7,7 and 8 respectively; the second part has 2 digits, 8 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 577778-86:
(8*5)+(7*7)+(6*7)+(5*7)+(4*7)+(3*8)+(2*8)+(1*6)=240
240 % 10 = 0
So 577778-86-0 is a valid CAS Registry Number.
577778-86-0Relevant academic research and scientific papers
NOVEL 1,2,4-TRIAZOLE COMPOUND
-
Page 12, (2010/02/08)
A novel 1,2,4-triazole compound which is useful as a therapeutic agent for hyperuricemia and gout due to hyperuricemia is provided. A compound is represented by the following general formula (1): wherein R2 represents an unsubstituted or substituted pyridyl group, R1 represents a similar pyridyl group, a pyridine-N-oxide group corresponding to these pyridyl groups, or a phenyl group, and R3 represents hydrogen or a lower alkyl group substituted with pivaloyloxy group and R3 bonds to a nitrogen atom in the ring. A process for production of a compound by reacting a nitrile and a hydrazide, and a therapeutic agent, particularly a xanthine oxidase inhibitor are also provided.
